BC
Boxer Capital Portfolio holdings
AUM
$2.04B
This Quarter Return
-6.36%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$1.58B
AUM Growth
-$367M
(-19%)
Cap. Flow
-$12.5M
Cap. Flow
% of AUM
-0.79%
Top 10 Holdings %
Top 10 Hldgs %
42.1%
Holding
79
New
5
Increased
1
Reduced
2
Closed
3
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
$15M |
| 2 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$12.8M |
| 3 |
Ascendis Pharma
ASND
|
$6.51M |
| 4 |
89bio
ETNB
|
$4.51M |
| 5 |
Cogent Biosciences
COGT
|
$3.83M |
Top Sells
| 1 |
ITOS
iTeos Therapeutics
ITOS
|
$21.4M |
| 2 |
SPDR S&P Biotech ETF
XBI
|
$14.9M |
| 3 |
Ultragenyx Pharmaceutical
RARE
|
$14.5M |
| 4 |
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
|
$5.55M |
| 5 |
GNCA
Genocea Biosciences, Inc.
GNCA
|
$1.42M |
Sector Composition
| 1 | Healthcare | 96.9% |
| 2 | Financials | 0.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Surrozen, Inc. Warrant
SRZNW
$71.9K
| $13K | ﹤0.01% |
66,666
| – | – |
|
|
77
Ultragenyx Pharmaceutical
RARE
$3.04B
| – | – |
-200,000
| Closed | -$14.5M |
|
|
ODT
78
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| – | – |
-4,207,086
| Closed | -$5.55M |
|
|
GNCA
79
DELISTED
Genocea Biosciences, Inc.
GNCA
| – | – |
-1,134,453
| Closed | -$1.42M |
|